Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
23-25 May, 2025
Not Confirmed
Not Confirmed
26-27 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
23-25 May, 2025
Industry Trade Show
Not Confirmed
26-27 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
14 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/14/3081070/0/en/Indaptus-Therapeutics-Reports-First-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html
08 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/08/3077182/0/en/Indaptus-Therapeutics-Founder-and-Chief-Scientific-Officer-Dr-Michael-Newman-Named-Chair-and-Expert-Speaker-at-6th-Annual-Cytokine-Based-Drug-Development-Summit.html
25 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/25/3048658/0/en/Indaptus-Therapeutics-Chief-Medical-Officer-Roger-Waltzman-M-D-M-B-A-to-Moderate-Panel-at-CMO360-Summit.html
20 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/20/3046168/0/en/Indaptus-Therapeutics-Reports-New-Data-Demonstrating-Successful-Broad-Immune-System-Activation-in-Weekly-Dosing-Trial-of-Decoy20.html
18 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2025/03/18/3044457/0/en/Indaptus-Therapeutics-Initiates-Phase-1-Combination-Study-of-Decoy20-with-PD-1-Checkpoint-Inhibitor-Tislelizumab.html
13 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/13/3042088/0/en/Indaptus-Therapeutics-Reports-Fourth-Quarter-and-Year-End-2024-Financial-Results-and-Provides-Corporate-Update.html
ABOUT THIS PAGE